Shoulder Innovations Announces Closing of up to $50 Million Credit Facility

Shoulder Innovations (NYSE: SI) closed new credit facilities totaling up to $50 million with Stifel Venture Banking, refinancing its existing debt.

Rhea-AI Summary

Shoulder Innovations (NYSE: SI) closed new credit facilities totaling up to $50 million with Stifel Venture Banking, refinancing its existing debt.

The package includes a fully funded $15 million term loan, a $30 million undrawn line of credit, and a $5 million accordion, with no added indebtedness at closing and no warrants.

Positive

• Refinances existing debt with up to $50 million in new credit capacity
• $15 million growth capital term loan fully funded at closing
• $30 million undrawn working capital line plus $5 million accordion feature
• Term loan interest-only through June 30, 2029, maturing in June 2031
• No additional indebtedness at closing and no warrants attached to the facilities
• Interest rates tied to prime with minimums of 5.00% on both facilities

Negative

• None.

Argus Jun 29 session

-7.46% close to close Open Argus

Details

News Market Reaction – SI

On Jun 29, the day this news came out, SI closed 7.46% below the previous close.

Data tracked by StockTitan Argus for the Jun 29 session.

Market Context

On Jun 29, the day this news came out, the stock closed 7.5% below the previous close. A negative re...

Analysis

On Jun 29, the day this news came out, the stock closed 7.5% below the previous close. A negative reaction despite positive refinancing terms would fit a pattern where some non-earnings news underperforms. The facility’s up to $50 million capacity aids flexibility, but higher debt obligations could still concern investors over time.

Key Figures

Aggregate credit capacity: up to $50 million Growth capital term loan: $15 million Undrawn line of credit: $30 million +5 more

Aggregate credit capacity

up to $50 million

Total amount under new credit facilities with Stifel Venture Banking

Growth capital term loan

$15 million

Fully funded at closing to refinance existing credit facility

Undrawn line of credit

$30 million

Additional working capital capacity, undrawn at closing

Accordion feature

$5 million

Incremental capacity available upon request, subject to conditions

Term loan interest floor

5.00%

Annual rate is greater of 0.75% below prime or 5.00%

Line of credit rate

>= prime rate or 5.00%

Annual rate is greater of prime rate or 5.00%

Interest-only period

through June 30, 2029

Term loan interest-only period before principal amortization

Maturities

June 2029 & June 2031

Line of credit matures June 2029; term loan June 2031

Historical Context

5 past events · Latest: May 26

5 events

1. May 26

   Conference participation

   24h Move

   -0.6%

   Announcement of participation in Goldman Sachs healthcare conference in June 2026.

2. May 13

   Earnings report

   24h Move

   +15.2%

   Strong Q1 2026 results and raised full-year revenue outlook.

3. Apr 27

   Product launch

   24h Move

   +4.3%

   Full commercial launch of the InSet I-135RFX humeral stem after 510(k) clearance.

4. Apr 22

   Earnings date announcement

   24h Move

   -4.5%

   Scheduling update for upcoming Q1 2026 earnings release and conference call details.

5. Mar 10

   Earnings report

   24h Move

   +7.4%

   Strong Q4 and full-year 2025 revenue growth with solid gross margins and 2026 guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

accordion feature, prime rate, line of credit, interest-only

4 terms

accordion feature financial

"a $30 million undrawn line of credit, with an additional $5 million accordion feature"

An accordion feature is a clause in a loan or financing agreement that allows a company to expand the size of a credit line or the amount of securities available under the same contract without drafting a completely new deal. Like a suitcase that can be extended to hold more items, it gives a company quick flexibility to raise extra money, which can help fund growth but may increase debt or dilute existing shareholders—so investors watch it for changes in risk and ownership.

prime rate financial

"annual interest rate under the term loan is equal to the greater of (i) 0.75% below the prime rate"

The prime rate is the interest rate banks typically charge their most creditworthy customers for short-term loans and serves as a common baseline for many other interest rates. Think of it as a price tag for borrowing: when the prime rate rises, costs for business loans, mortgages and consumer credit usually go up, which can slow spending, squeeze profits and influence stock prices and interest-sensitive sectors.

line of credit financial

"and a $30 million undrawn line of credit, with an additional $5 million accordion feature"

A line of credit is a flexible borrowing arrangement that lets a company draw money up to a preset limit, repay it, and borrow again as needed—similar to a business credit card or an emergency tap on a savings account. It matters to investors because it shows how a firm manages short-term cash needs and growth funding without taking a single large loan; access, cost, and attached conditions can affect liquidity, interest expenses and financial risk.

interest-only financial

"The term loan is interest-only through June 30, 2029, and matures in June 2031"

A loan or payment plan where the borrower pays only the interest for a set period while the original loan amount (the principal) stays unchanged; after that period payments typically rise to cover principal or a lump-sum principal payment is due. For investors this matters because interest-only structures change cash flows and risk: they can boost short-term income but increase the chance of payment shock or default later, similar to renting a car without paying down the purchase cost until the final bill arrives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Refinancing Existing Debt with Significantly Improved Terms

Provides Additional Undrawn Working Capital Capacity  

GRAND RAPIDS, Mich., June 29, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the closing of two new credit facilities for an aggregate amount of up to $50 million with Stifel Venture Banking.

The new credit facilities consist of a $15 million growth capital term loan, fully funded at closing to refinance the Company's existing credit facility, and a $30 million undrawn line of credit, with an additional $5 million accordion feature available upon the Company's request, subject to certain conditions. The annual interest rate under the term loan is equal to the greater of (i) 0.75% below the prime rate and (ii) 5.00%, and the annual interest rate under the line of credit is equal to the greater of (i) the prime rate and (ii) 5.00%. The term loan is interest-only through June 30, 2029, and matures in June 2031, and the line of credit matures in June 2029. At close, the new credit facilities do not result in additional indebtedness and do not include warrants.

"This refinancing represents an important step in strengthening our financial foundation as we continue to rapidly scale Shoulder Innovations," said Jeff Points, Chief Financial Officer of Shoulder Innovations. "The new credit facility significantly improves the economics of our existing debt structure, provides additional financial flexibility, and better aligns our lender relationships with the current stage of our business. We are pleased to partner with Stifel Venture Banking, whose platform and resources are well suited to support our needs today and to grow with us over time."

Additional information regarding the new credit facility and the refinancing of the Company's existing credit facility will be included in a Current Report on Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

About Stifel Venture Banking
Stifel Venture Banking, a division of Stifel Bank, Member FDIC, provides commercial banking and debt capital financing solutions to venture capital-backed technology companies and their investors.

Contact 
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-announces-closing-of-up-to-50-million-credit-facility-302812585.html

SOURCE Shoulder Innovations

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Shoulder Innovations (NYSE: SI) announce on June 29, 2026 about its credit facility?

Shoulder Innovations announced closing new credit facilities of up to $50 million to refinance existing debt. According to Shoulder Innovations, this includes a $15 million term loan and a $30 million undrawn credit line, plus a $5 million accordion feature.

How large is the new Shoulder Innovations (SI) credit facility with Stifel Venture Banking?

The new credit facilities provide up to $50 million in total borrowing capacity. According to Shoulder Innovations, this includes a $15 million growth capital term loan, a $30 million undrawn line of credit, and an additional $5 million accordion feature subject to conditions.

What are the interest rates on Shoulder Innovations (SI) June 2026 term loan and credit line?

The term loan rate is the greater of 0.75% below prime or 5.00%, while the line uses the greater of prime or 5.00%. According to Shoulder Innovations, these rates apply to the $15 million term loan and $30 million credit line.

When do Shoulder Innovations' (SI) new credit facilities mature and what are the interest-only terms?

The term loan is interest-only through June 30, 2029 and matures in June 2031, while the credit line matures in June 2029. According to Shoulder Innovations, this structure is designed to support scaling the business.

Does the new Shoulder Innovations (SI) credit facility increase debt or include warrants for lenders?

At closing, the new facilities do not increase total indebtedness and include no warrants. According to Shoulder Innovations, the $15 million term loan refinances the existing facility while maintaining a neutral debt balance at close.

How might Shoulder Innovations' (SI) new $50 million credit facility affect liquidity and flexibility?

The facilities are intended to enhance liquidity and financial flexibility by adding undrawn working capital capacity. According to Shoulder Innovations, the $30 million line of credit and $5 million accordion can support ongoing growth without immediate additional borrowing.